ArticleFrontiers in cell and developmental biology2026
Fibronectin is required for proper extracellular matrix organization and cardiac outflow tract elongation in
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Congenital heart defects frequently arise from alterations in cardiac outflow tract (OFT) elongation, a process that depends on the coordinated deployment of second heart field (SHF) progenitor cells and their interactions with the extracellular matrix (ECM). Among ECM components, fibronectin (Fn1) and tenascin-C (TnC) have emerged as key regulators of cardiac morphogenesis; however, the cellular organization of the SHF and the dynamics of its ECM environment remain poorly characterized in externally developing vertebrate models. Methods: Here, we investigated the cellular and extracellular architecture of SHF-associated cells localized to the dorsal pericardial wall (DPW) during heart development in Xenopus laevis using immunofluorescence, three-dimensional reconstructions, quantitative analyses, and functional depletion experiments. Results: We found that SHF-associated cells undergo a stage-dependent transition from a predominantly monolayered organization at NF35 to a multilayered structure at NF42, accompanied by dynamic ECM remodeling characterized by increased expression of Fn1, TnC, and collagen I (Col I), as well as redistribution of ECM components within the DPW. Functional depletion of Fn1 disrupted cardiac morphogenesis, resulting in OFT shortening and reduced ventricular size, while also decreasing TnC and Col I levels without affecting TnC spatial organization within the DPW. Conclusion: Together, these findings support a role for Fn1 in regulating ECM assembly within SHF-associated cells and demonstrate that ECM remodeling contributes to DPW organization during OFT elongation, highlighting Xenopus laevis as a valuable model for studying ECM-driven mechanisms of cardiac morphogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.